Table 1 Baseline characteristics of the study group (n = 32)

Age*

(years)

31.3 ± 3.2

29.7 ± 2.9

32.4 ± 2.9

BMI

(kg/m²)

21.3 ± 1.5

21.3 ± 1.7

21.3 ± 1.4

Cycle length

(days)

28.7 ± 2.1

29 ± 2.2

28.5 ± 1.5

Nicotine abuse

(pack years)

-

-

14.8 ± 4.6

RR syst

(mmHg)

98 ± 33

102 ± 30

94 ± 36

RR diast

(mmHg)

65 ± 22

67 ± 20

63 ± 25

Total cholesterol

(mg/dl)

164 ± 23

158 ± 17

168 ± 27

HDL

(mg/dl)

64.4 ± 10.1

66.9 ± 9.1

62.2 ± 10.7

LDL

(mg/dl)

85.8 ± 24.5

79.9 ± 16.5

91.1 ± 29.4

Triglyceride

(mg/dl)

67.7 ± 28.4

57.5 ± 13.4

76.7 ± 35.0

Lipoprotein(a)

(mg/dl)

7.0 ± 4.0

7.4 ± 4.2

6.6 ± 3.8

hsCrP

(mg/dl)

0.08 ± 0.07

0.09 ± 0.08

0.08 ± 0.06

Insulin

(mIU/l)

5.6 ± 2.2

5.2 ± 2.1

6.0 ± 2.3

Glucose

(mg/dl)

87.7 ± 7.2

87.0 ± 4.9

88.4 ± 8.8

Homocystein

(μmol/l)

8.5 ± 1.7

8.2 ± 1.7

8.7 ± 1.8

Folic acid

(μg/l)

8.8 ± 4.5

10.2 ± 5.6

7.6 ± 2.8

Uric acid

(μmol/l)

3.9 ± 0.9

3.7 ± 0.9

4.1 ± 0.8

Estradiol

(pmol/l)

613 ± 194

598 ± 191

626 ± 201

Progesterone

(nmol/l)

51.4 ± 17.6

51.2 ± 16.4

51.5 ± 19.2

LH

(IU/l)

4.7 ± 2.9

4.5 ± 3.8

4.9 ± 2.0

FSH

(IU/l)

2.7 ± 1.2

2.8 ± 1.5

2.7 ± 0.7